Exelixis
EXEL
#1786
Rank
โ‚ฌ9.04 B
Marketcap
31,67ย โ‚ฌ
Share price
-0.09%
Change (1 day)
56.89%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company